Literature DB >> 10797316

Grb7 signal transduction protein mediates metastatic progression of esophageal carcinoma.

S Tanaka1, K Sugimachi, H Kawaguchi, H Saeki, S Ohno, J R Wands.   

Abstract

We have previously reported the association of tumor cell invasion with expression of growth factor receptor-bound protein 7 (Grb7). This molecule contains a Src homology 2 (SH2) domain and shares structural homology with a cell migration molecule designated Mig-10 found in Caenorhabditis elegans. In the present study, Grb7 expression was analyzed in human esophageal carcinomas with or without metastatic spread. The Grb7 protein was overexpressed in 14 of 31 esophageal carcinomas as compared to the adjacent normal mucosa (45%) and this finding was significantly correlated with the presence of lymph node metastases. We also identified that Grb7 protein in esophageal carcinoma cells was phosphorylated on tyrosine by epidermal growth factor as well as attachment to extracellular matrix proteins including fibronectin. Such fibronectin-dependent phosphorylation of Grb7 was regulated by integrin signaling that leads to the interaction with focal adhesion kinase protein. Furthermore, ectopic expression of a Grb7-SH2 dominant-negative fragment inhibited the fibronectin-dependent phosphorylation of endogenous Grb7, and reduced migration of esophageal carcinoma cells into fibronectin. Our results suggest a role of Grb7 mediated signal transduction in generation of an invasive cell phenotype against extracellular matrix, and thus contributes to metastatic progression of human esophageal carcinoma. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10797316     DOI: 10.1002/(SICI)1097-4652(200006)183:3<411::AID-JCP14>3.0.CO;2-Z

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  13 in total

1.  Role for the adaptor protein Grb10 in the activation of Akt.

Authors:  Thomas Jahn; Petra Seipel; Susanne Urschel; Christian Peschel; Justus Duyster
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

2.  EGF-induced Grb7 recruits and promotes Ras activity essential for the tumorigenicity of Sk-Br3 breast cancer cells.

Authors:  Pei-Yu Chu; Tsai-Kun Li; Shih-Torng Ding; I-Rue Lai; Tang-Long Shen
Journal:  J Biol Chem       Date:  2010-07-09       Impact factor: 5.157

3.  Grb7-SH2 domain dimerisation is affected by a single point mutation.

Authors:  Corrine J Porter; Matthew C J Wilce; Joel P Mackay; Peter Leedman; Jackie A Wilce
Journal:  Eur Biophys J       Date:  2005-04-20       Impact factor: 1.733

4.  The cell migration protein Grb7 associates with transcriptional regulator FHL2 in a Grb7 phosphorylation-dependent manner.

Authors:  Sharareh Siamakpour-Reihani; Haroula J Argiros; Lori J Wilmeth; L Lowell Haas; Tabitha A Peterson; Dennis L Johnson; Charles Brad Shuster; Barbara A Lyons
Journal:  J Mol Recognit       Date:  2009 Jan-Feb       Impact factor: 2.137

5.  Grb7 gene amplification and protein expression by FISH and IHC in ovarian cancer.

Authors:  Manman Zeng; Zhu Yang; Xiaoyu Hu; Yi Liu; Xiaotao Yang; Hailong Ran; Yanan Li; Xu Li; Qiubo Yu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

6.  An Integrative Analysis to Identify Driver Genes in Esophageal Squamous Cell Carcinoma.

Authors:  Genta Sawada; Atsushi Niida; Hidenari Hirata; Hisateru Komatsu; Ryutaro Uchi; Teppei Shimamura; Yusuke Takahashi; Junji Kurashige; Tae Matsumura; Hiroki Ueo; Yuki Takano; Masami Ueda; Shotaro Sakimura; Yoshiaki Shinden; Hidetoshi Eguchi; Tomoya Sudo; Keishi Sugimachi; Makoto Yamasaki; Fumiaki Tanaka; Yuji Tachimori; Yoshiaki Kajiyama; Shoji Natsugoe; Hiromasa Fujita; Yoichi Tanaka; George Calin; Satoru Miyano; Yuichiro Doki; Masaki Mori; Koshi Mimori
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

7.  Targeting GRB7/ERK/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cells.

Authors:  David W Chan; Winnie W Y Hui; Patty C H Cai; Michelle X Liu; Mingo M H Yung; Celia S L Mak; Thomas H Y Leung; Karen K L Chan; Hextan Y S Ngan
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

8.  Combination treatment with Grb7 peptide and Doxorubicin or Trastuzumab (Herceptin) results in cooperative cell growth inhibition in breast cancer cells.

Authors:  S C Pero; G S Shukla; M M Cookson; S Flemer; D N Krag
Journal:  Br J Cancer       Date:  2007-04-10       Impact factor: 7.640

9.  Grb7 Protein Stability Modulated by Pin1 in Association with Cell Cycle Progression.

Authors:  Yu-Ling Tai; Li-Hsuan Tung; Yu-Chi Lin; Pei-Jung Lu; Pei-Yu Chu; Ming-Yang Wang; Wei-Pang Huang; Ko-Chien Chen; Hsinyu Lee; Tang-Long Shen
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

10.  Insight into the Selectivity of the G7-18NATE Inhibitor Peptide for the Grb7-SH2 Domain Target.

Authors:  Gabrielle M Watson; William A H Lucas; Menachem J Gunzburg; Jacqueline A Wilce
Journal:  Front Mol Biosci       Date:  2017-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.